155
Participants
Start Date
March 7, 2018
Primary Completion Date
April 5, 2023
Study Completion Date
October 30, 2024
PF-06873600
PF-06873600 tablet for oral dosing
Endocrine Therapy 1
Endocrine Therapy 1
Endocrine Therapy 2
Endocrine Therapy 2
Complex Oncology Center -Plovdiv, Plovdiv
Specialized Hospital for Active Treatment of Oncology - Haskovo EOOD, Haskovo
Multiprofile Hospital of Active Treatment - Dobrich AD, Dobrich
Memorial Sloan Kettering Cancer Center, New York
Memorial Sloan Kettering Cancer Center, Long Island City
Holy Cross Hospital, Fort Lauderdale
University of Alabama at Birmingham, Birmingham
University Of Alabama at Birmingham, Birmingham
Tennessee Oncology, PLLC, Nashville
The Sarah Cannon Research Institute-Pharmacy, Nashville
The Sarah Cannon Research Institute, Nashville
"Municipal Non-profit Enterprise City Clinical Hospital #4 of Dnipro City Council, Dnipro State Me", Dnipro
Kharkiv Regional Specialized Dispensary of Radiation Protection of the Population, Kharkiv
Highlands Oncology Group, Fayetteville
Highlands Oncology Group, Rogers
Highlands Oncology Group, Springdale
Highlands Oncology, Springdale
The University of Texas MD Anderson Cancer Center, Houston
South Texas Accelerated Research Therapeutics, LLC, San Antonio
"Communal noncommercial enterprise of Lviv regional council Lviv oncological regional therapeutical", Lviv
University of Colorado Hospital - Anschutz Cancer Pavilion (ACP), Aurora
University of Colorado Hospital - Anschutz Inpatient Pavilion (AIP), Aurora
University of Colorado Hospital - Anschutz Outpatient Pavilion (AOP), Aurora
UCHealth Lone Tree Medical Center, Lone Tree
HonorHealth, Scottsdale
Virginia G. Piper Cancer Center Pharmacy, Scottsdale
UCLA Hematology/Oncology - Parkside, Santa Monica
UCLA Hematology/Oncology - Santa Monica, Santa Monica
The Oncology Institute of Hope and Innovation, Whittier
The Oncology Institute of Hope and Innovation, Long Beach
The Oncology Institute of Hope and Innovation, Glendale
The Oncology Institute of Hope and Innovation, Santa Ana
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
UCSF Investigational Drugs Pharmacy, San Francisco
Northwest Medical Specialties, PLLC, Federal Way
Fred Hutchinson Cancer Center, Seattle
University of Washington Medical Center, Seattle
Northwest Medical Specialties, PLLC, Gig Harbor
Rainier Hematology-Oncology PC, Puyallup
Rainier Hematology-Oncology, PC, Puyallup
Northwest Medical Specialties, PLLC, Tacoma
"LLC Medicina Severnoy Stolitsy", Saint Petersburg
"LLC Severo-Zapadny Medical Center", Saint Petersburg
"Private Medical Institution Euromedservice", Pushkin
"BIH of Omsk Region Clinical Oncological Dispensary", Omsk
"BIH of Omsk Region Clinical Oncological Dispensary", Omsk
Kanagawa cancer center, Yokohama
Massachusetts General Hospital, Boston
Brigham & Women's Hospital, Boston
Dana Farber Cancer Institute, Boston
Dana-Farber Cancer Institute, Boston
McGill University Health Centre, Montreal
National Cancer Center Hospital East, Kashiwa
"Communal nonprofit enterprise Kyiv City Clinical Oncology Center of Executive Body of Kyiv City", Kyiv
Lead Sponsor
Pfizer
INDUSTRY